Product Classification by Usage Cycle

Bone marrow biopsy needles are divided into disposable sterile biopsy needles and reusable medical biopsy needles according to usage attributes. Disposable products are sterilized independently for one-time use, while reusable products adopt high-quality alloy materials and support repeated sterilization and clinical use. The two types have obvious differences in infection risk, economic cost, operational standardization and applicable scenarios, forming a differentiated market pattern.

Core Advantages of Disposable Bone Marrow Biopsy Needles

Zero Cross-Infection Risk

Disposable biopsy needles are used immediately after opening and discarded after operation, completely avoiding residual blood, tissue fluid and pathogen cross-transmission risks caused by incomplete disinfection of reusable instruments. They fully meet modern hospital nosocomial infection control standards.

Stable Product Consistency

Mass-produced disposable needles have unified standards in needle tip sharpness, shaft rigidity and scale accuracy, without performance attenuation caused by repeated sterilization and use. Each operation can maintain the best puncture state and stable sampling quality.

Simple Clinical Process

Disposable products eliminate the links of instrument recycling, cleaning, disinfection and sterilization, greatly reducing the workload of nursing and disinfection departments, improving clinical turnover efficiency and adapting to high-volume outpatient diagnosis scenarios.

Core Advantages of Reusable Bone Marrow Biopsy Needles

Ultra-Long Service Life

Reusable biopsy needles are made of high-strength titanium alloy and high-quality stainless steel, resisting high temperature and high pressure sterilization. They can be reused dozens of times after standardized disinfection, with low average single-use cost.

High Structural Stability

Reusable products adopt thickened needle wall and reinforced structure design, with stronger anti-deformation ability and more durable cutting performance. They are suitable for long-term repeated use in fixed professional departments.

Cost Advantage for Long-Term Fixed Use

For professional hematology laboratories and scientific research institutions with long-term and high-frequency use, reusable needles can effectively reduce long-term procurement costs and improve resource utilization efficiency.

Scenario Differentiation and Industry Trend

At present, global medical institutions are gradually upgrading to disposable bone marrow biopsy needles as the mainstream, driven by nosocomial infection control policies and standardized diagnosis requirements. Disposable products occupy the mainstream market of outpatient routine diagnosis, emergency treatment and primary medical care. Reusable products are only retained in a small number of professional research laboratories and specialized fixed departments. In the future, with the continuous improvement of medical safety standards, disposable minimally invasive biopsy needles will further expand market share.